EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Clinical trials for EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing if a new combination treatment is safe and effective for people with a hard-to-treat form of multiple myeloma that has spread to soft tissues. It combines a targeted cancer drug (talquetamab) with a short course of focused radiation aimed at one of the cance…
Matched conditions: EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo targets aggressive blood cancer spread
Disease control Recruiting nowThis study is testing a combination of three drugs—mezigdomide, carfilzomib, and dexamethasone—to see if it can control multiple myeloma that has come back or stopped responding to other treatments and has spread to form tumors in soft tissues or organs. It will involve about 28 …
Matched conditions: EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC